Bimatoprost as a Treatment for Graves' Orbitopathy
ConditionGraves Ophthalmopathy
Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18+
SponsorJohns Hopkins University
About this trial
Testing whether Bimatoprost, a topical eye drop used for glaucoma, can be used to induce periorbital fat atrophy in patients with Graves' disease
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Bimatoprost Ophthalmic
Treatment groups
3 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov